Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden...

                   
redorbit.com     May 14, 2008            

NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS(TM) cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM) implantable cardioverter defibrillator (ICD). [read full story]                

Full Coverage
                   

Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden...

prnewswire.com     May 13, 2008          

Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death COGNIS(TM) CRT-D and TELIGEN(TM) ICD represent entirely new platforms NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and...                

comments

Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data

prnewswire.com     May 15, 2008          

Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy NATICK, Mass., May 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced a new clinical...                

comments

Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data

redorbit.com     May 15, 2008          

Posted on: Thursday, 15 May 2008, 09:01 CDT NATICK, Mass., May 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced a new clinical science initiative, ALTITUDE, which will analyze data(1) from the LATITUDE(R) Patient Management system. Boston Scientific has enrolled nearly...                

comments

                   

Boston Scientific Announces FDA Approval of New Heart Failure Lead

prnewswire.com     May 16, 2008          

Boston Scientific Announces FDA Approval of New Heart Failure Lead ACUITY(R) Spiral lead has smallest left ventricular lead tip profile in the industry NATICK, Mass., May 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA)...                

comments

                   

Boston Scientific Announces FDA Approval of New Heart Failure Lead

redorbit.com     May 16, 2008          

Posted on: Friday, 16 May 2008, 12:00 CDT NATICK, Mass., May 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY(R) Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators...                

comments

                   

Boston Scientific Announces FDA Approval of New Heart Failure Lead (PR Newswire)

yahoo.com     May 16, 2008          

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its ACUITY® Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers , both of which treat heart failure.                

comments